Citicoline in the treatment of Parkinson's disease

The subjects were 20 patients with Parkinson's disease. They were aged 52 to 76 years and the duration of the disease ranged from four to 25 years (mean, 12.5 years). All the patients were receiving levodopa alone or in combination with tricyclic antidepressants, amantadine, bromocriptine, anti...

Full description

Saved in:
Bibliographic Details
Published inClinical therapeutics Vol. 13; no. 2; p. 239
Main Authors Martí Massó, J F, Urtasun, M
Format Journal Article
LanguageEnglish
Published United States 01.03.1991
Subjects
Aged
Cytidine Diphosphate Choline - administration & dosage
Cytidine Diphosphate Choline - therapeutic use
Dose-Response Relationship, Drug
Female
Humans
Infusions, Intravenous
Injections, Intramuscular
Injections, Subcutaneous
Male
Middle Aged
Parkinson Disease - drug therapy
Prospective Studies
Online AccessGet more information

Cover

More Information
Summary:The subjects were 20 patients with Parkinson's disease. They were aged 52 to 76 years and the duration of the disease ranged from four to 25 years (mean, 12.5 years). All the patients were receiving levodopa alone or in combination with tricyclic antidepressants, amantadine, bromocriptine, anticholinergic agents, or lisuride. Each patient received 1,000 mg of citicoline intramuscularly daily for 15 days and then 500 mg daily for 15 days. After 30 days of treatment, the scores on the Columbia rating scale improved 7.3%; rigidity was improved 18.8%; times to walk 10 m and turn over were reduced 17.5% and 37.4%; and the handwriting test scores improved 19.7%. No side effects were reported. Four patients with advanced parkinsonian symptoms and psychotic side effects received 2,000 mg of citicoline subcutaneously or intravenously for seven days. No improvements in symptoms or treatment side effects were noted.
ISSN:0149-2918
1879-114X